Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Is Crinetics Pharmaceuticals Stock a Buy?
George Budwell
|
Sep 28, 2025
The FDA just handed this clinical-stage biotech its golden ticket -- but at a $4.3 billion valuation, the market's already pricing in a fair amount of commercial success.
bioAffinity Misses Q2 Revenue Target
Motley Fool Markets Team
|
Aug 14, 2025
Aqua Metals Hits Lithium Purity Record
Motley Fool Markets Team
|
Aug 13, 2025
Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?
Alex Carchidi
|
Sep 19, 2023
Despite good results in phase 3 trials, there are barriers to its drug candidate's success.
Why Crinetics Pharmaceuticals Stock Soared This Week
George Budwell
|
Sep 15, 2023
A positive late-stage trial readout fueled a major rally in the drugmaker's shares.
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday
James Halley
|
Sep 11, 2023
The biotech company reported positive phase 3 trial results.
Aqua Metals (AQMS) Q2 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Jul 30, 2021
AQMS earnings call for the period ending June 30, 2021.
Aqua Metals (AQMS) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Apr 30, 2021
AQMS earnings call for the period ending March 31, 2021.
View More Articles